Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Marini

Showing results (181-190 of 227) with videos related to

Pageof 23
Sort By:
British Journal of Rheumatology|April 1, 1996
A 4-week, double-blind, parallel-group study to compare the gastrointestinal effects of meloxicam 7.5 mg, meloxicam 15 mg, piroxicam 20 mg and placebo by means of faecal blood loss, endoscopy and symptom evaluation in healthy volunteersL Patoia, L Santucci, P Furno, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|September 1, 1992
A novel pharmacological approach for paraquat poisoning in rat and A549 cell line using ambroxol, a lung surfactant synthesis inducerM Salmona, M Donnini, L Perin, et al.
Tumori|April 30, 1991
Mitomycin-C, adriamycin, 5-fluorouracil and leucovorin (L-FAM2) in the treatment of advanced gastric cancer: a phase II studyA Zaniboni, E Simoncini, P Marpicati, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|February 13, 2009
Radio hyperthermia for re-treatment of superficial tumoursP Gabriele, T Ferrara, B Baiotto, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|December 1, 1987
Cisplatin, high dose folinic acid and 5-fluorouracil in squamous cell carcinoma of the esophagus. A pilot studyA Zaniboni, E Simoncini, G Tonini, et al.
European Review for Medical and Pharmacological Sciences|November 14, 2017
Imaging assessment of portal venous system: pictorial essay of normal anatomy, anatomic variants and congenital anomaliesA Guerra, A M De Gaetano, A Infante, et al.
Journal of Chemotherapy (Florence, Italy)|February 1, 1996
Sequential methotrexate and 5-fluorouracil as second-line chemotherapy for advanced colorectal cancer patients pretreated with 5-fluorouracil and leucovorin: a GISCAD studyA Zaniboni, R Labianca, G Martignoni, et al.
Cancer|November 15, 1995
Epirubicin, cisplatin, and continuous infusion 5-fluorouracil is an active and safe regimen for patients with advanced gastric cancer. An Italian Group for the Study of Digestive Tract Cancer (GISCAD) reportA Zaniboni, S Barni, R Labianca, et al.
Journal of Chemotherapy (Florence, Italy)|June 1, 1991
Fluorouracil, high-dose folinic acid, low-dose alpha-2b interferon and dipyridamole in the treatment of advanced colorectal cancer. A pilot studyA Zaniboni, P Marpicati, E Simoncini, et al.
European Review for Medical and Pharmacological Sciences|December 5, 2019
Minimal impact of lenvatinib (Lenvima®) on muscle mass in advanced hepatocellular carcinoma and implications for treatment duration. Two cases from the REFLECT studyE Rinninella, M Cintoni, P Raoul, et al.
Pageof 23

Showing results (181-190 of 227) with videos related to

Sort By:
Pageof 23
British Journal of Rheumatology|April 1, 1996
A 4-week, double-blind, parallel-group study to compare the gastrointestinal effects of meloxicam 7.5 mg, meloxicam 15 mg, piroxicam 20 mg and placebo by means of faecal blood loss, endoscopy and symptom evaluation in healthy volunteersL Patoia, L Santucci, P Furno, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|September 1, 1992
A novel pharmacological approach for paraquat poisoning in rat and A549 cell line using ambroxol, a lung surfactant synthesis inducerM Salmona, M Donnini, L Perin, et al.
Tumori|April 30, 1991
Mitomycin-C, adriamycin, 5-fluorouracil and leucovorin (L-FAM2) in the treatment of advanced gastric cancer: a phase II studyA Zaniboni, E Simoncini, P Marpicati, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|February 13, 2009
Radio hyperthermia for re-treatment of superficial tumoursP Gabriele, T Ferrara, B Baiotto, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|December 1, 1987
Cisplatin, high dose folinic acid and 5-fluorouracil in squamous cell carcinoma of the esophagus. A pilot studyA Zaniboni, E Simoncini, G Tonini, et al.
European Review for Medical and Pharmacological Sciences|November 14, 2017
Imaging assessment of portal venous system: pictorial essay of normal anatomy, anatomic variants and congenital anomaliesA Guerra, A M De Gaetano, A Infante, et al.
Journal of Chemotherapy (Florence, Italy)|February 1, 1996
Sequential methotrexate and 5-fluorouracil as second-line chemotherapy for advanced colorectal cancer patients pretreated with 5-fluorouracil and leucovorin: a GISCAD studyA Zaniboni, R Labianca, G Martignoni, et al.
Cancer|November 15, 1995
Epirubicin, cisplatin, and continuous infusion 5-fluorouracil is an active and safe regimen for patients with advanced gastric cancer. An Italian Group for the Study of Digestive Tract Cancer (GISCAD) reportA Zaniboni, S Barni, R Labianca, et al.
Journal of Chemotherapy (Florence, Italy)|June 1, 1991
Fluorouracil, high-dose folinic acid, low-dose alpha-2b interferon and dipyridamole in the treatment of advanced colorectal cancer. A pilot studyA Zaniboni, P Marpicati, E Simoncini, et al.
European Review for Medical and Pharmacological Sciences|December 5, 2019
Minimal impact of lenvatinib (Lenvima®) on muscle mass in advanced hepatocellular carcinoma and implications for treatment duration. Two cases from the REFLECT studyE Rinninella, M Cintoni, P Raoul, et al.
Pageof 23